Evidence map›Paper›PMID 9736711›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling.

R Dahl, M Kieslinger, H Beug, M J Hayman

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Strain-specific modifier genes governing craniofacial phenotypes.Birth defects research. Part A, Clinical and molecular teratology · 2012
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Ski protein negatively regulates Siah2-mediated HDAC3 degradation.Biochemical and biophysical research communications · 2010
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

R DahlDepartment of Molecular Genetics and Microbiology and Institute of Cell and Developmental Biology, State University of New York, Stony Brook, NY 11794-5222, USA.
M Kieslinger
H Beug
M J Hayman
Research Institute of Molecular Pathology · AT

Funding

TUMOR VIRUS-HOST INTERACTIONSP01CA028146 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HEARING, PATRICK · 1986 to 2005
$9.9M
MECHANISM OF ACTION OF THE SKI ONCOGENER01CA042573 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HAYMAN, MICHAEL JOHN · 1986 to 2005
$1.7M
NCI NIH HHS CA28146NCI NIH HHS CA42573NCI NIH HHS P01 CA028146NCI NIH HHS R01 CA042573
6 · The paper itself

Abstract

The Ski oncogene has dramatic effects on the differentiation of several different cell types. It induces the differentiation of quail embryo cells into myoblasts and arrests the differentiation of chicken hematopoietic cells. The mechanism that Ski uses to carry out these disparate biological activities is unknown. However, we were struck by the similarity of these effects to those of certain members of the nuclear hormone receptor family. Both Ski and the thyroid hormone receptor-derived oncogene v-ErbA can arrest the differentiation of avian erythroblasts, and v-Ski-transformed avian multipotent progenitor cells resemble murine hematopoietic cells that express a dominant-negative form of the retinoic acid receptor, RARalpha. In this paper, we have tested the hypothesis that v-Ski and its cellular homologue c-Ski exert their effects by interfering with nuclear hormone receptor-induced transcription. We demonstrate that Ski associates with the RAR complex and can repress transcription from a retinoic acid response element. The physiological significance of this finding is demonstrated by the ability of high concentrations of a RARalpha-specific ligand to abolish v-Ski-induced transformation of the multipotent progenitors. These results strongly suggest that the ability of Ski to alter cell differentiation is caused in part by the modulation of RAR signaling pathways.

Indexed as

AnimalsBone Marrow CellsCell DifferentiationDNA-Binding ProteinsErythroblastsGenes, erbAHematopoiesisHistocytochemistryProtein BindingProto-Oncogene ProteinsReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoic Acid Receptor alphaSignal TransductionStem CellsTranscription, GeneticDNA-Binding ProteinsProto-Oncogene ProteinsReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoic Acid Receptor alphaTretinoin

Identifiers

PMID9736711
PMCPMC21617
OpenAlexW2059162630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.